SCHEMBL12246749

SCHEMBL12246749

Cc1cc(CCC(=O)NCCc2ccc(O)c(O)c2)ccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.65
HSD17B10 Q99714 3/20 0.65
TRPV1 Q8NER1 3/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
HPGD P15428 3/20 0.61
KDM4E B2RXH2 2/20 0.61
LMNA P02545 2/20 0.61
BLM P54132 2/20 0.61
HIF1A Q16665 2/20 0.61
ALDH1A1 P00352 2/20 0.61
PTGS1 P23219 1/20 0.61
ALOX12 P18054 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.57
NPC1 O15118 1/20 0.57
GMNN O75496 1/20 0.57
USP2 O75604 1/20 0.57
TP53 P04637 1/20 0.57
CYP1A2 P05177 1/20 0.57
POLB P06746 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL107219 0.91 MAPT (0.71) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL12246723 0.90 MAPT (0.53) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL12246698 0.90 KMT2A (0.54) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL12246697 0.89 MAPT (0.65) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL109158 0.86 MAPT (0.73) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL2378518 0.85 TRPV1 (0.68) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL31363209 0.85 TRPV1 (0.68) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL3324677 0.84 TRPV1 (0.84) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL8269764 0.84 MAPT (0.79) MAPTHSD17B10TRPV1MEN1KMT2A
SCHEMBL10029412 0.84 MAPT (0.70) MAPTHSD17B10TRPV1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9089499-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions UNIVERSITE JOSEPH FOURIER-GRENOBLE 1 (FR) 2015-07-28 US disclosed
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions Universite Joseph Fourier-Grenoble 1. (FR) 2013-10-17 US disclosed
US-8481593-B2 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions BASF BEAUTY CARE SOLUTIONS S.A.S. (FR) 2013-07-09 US disclosed
US-20110237551-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237551-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions TYR, CUTA, HPD MAPT 3126/4885HSD17B10 31/4885TRPV1 1020/4885
US-20130272983-A1 Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions TYR, CUTA, HPD MAPT 3115/4885HSD17B10 31/4885TRPV1 989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.